Category · Botanical
The WHO's own 2025-2034 strategy calls for standardising traditional botanicals into evidence-based therapies — a shift that's already reshaping how turmeric, ginseng, and Centella asiatica move from folk remedy to regulated supplement ingredient.
Global market, 2026
$263.84B
Growing to ~$396B by 2031, ~8.46% CAGR
Botanical supplements occupy a unique position in ASEAN: the underlying plants have centuries of traditional use across the region, but turning that traditional knowledge into a regulated, standardised, halal-certified supplement ingredient is a genuinely modern undertaking. This page covers the global policy shift pushing botanicals toward standardisation, what that means in practice for formulation, and which specific plant ingredients matter most in this category right now — from turmeric's dominant market share to ginseng's rapid growth.
The World Health Organization's Traditional Medicine Global Strategy 2025-2034 calls on member states to integrate evidence-based botanical therapies into national health systems — a meaningful shift from treating traditional plant remedies as folk medicine outside formal healthcare structures, toward requiring the same kind of standardisation and clinical validation expected of any other regulated health product. This isn't a distant policy abstraction for ASEAN brands: it directly shapes the direction national regulators are already moving, from stricter dossier requirements to growing expectations around documented compound levels rather than traditional preparation methods alone.
This shift matters particularly for ASEAN, where several of the world's most economically significant botanicals — Centella asiatica, ginger, and various traditional Malay and Indonesian remedies among them — are native to the region and deeply embedded in its Jamu, traditional Malay medicine (TMM), and other indigenous healing traditions. The WHO framework effectively asks the region to formalise what's already culturally established: a genuine opportunity for brands that can pair authentic traditional-use heritage with modern standardisation, rather than a threat to it.
Market size, 2026
$263.84B
Global herbal medicinal products market
Growth rate
~8.46% CAGR
Through 2031, per Mordor Intelligence
Regional leader
Asia-Pacific
Largest single regional revenue share
Term to know - standardised extract
An extract manufactured to guarantee a consistent, documented level of a specific active compound or compound group — as opposed to a traditional preparation where potency varies by harvest, region, and preparation method. Standardisation is what allows a traditional botanical to carry a reliable label claim and pass regulatory review as a supplement ingredient, batch after batch, market after market.
A traditional preparation of turmeric, ginger, or Centella asiatica can vary enormously in potency depending on the plant's growing conditions, harvest timing, and preparation method — none of which is a problem in a traditional-use context, but all of which is a genuine problem for a supplement label that needs to make a consistent, verifiable claim batch after batch. Standardising an extract to a documented level of curcuminoids, gingerols, or triterpenoids (depending on the plant) is what actually converts a traditional remedy into a supplement ingredient a regulator will accept and a brand can reliably market.
There's a genuine tension here worth naming honestly: some of what makes a traditional preparation feel authentic to consumers — regional variation, small-batch preparation, artisanal sourcing — is exactly what a standardised, scalable supplement extract has to control away. The brands that navigate this best don't pretend the tension doesn't exist; they use standardisation to guarantee the active compound consumers actually came for, while telling the cultural and geographic origin story honestly around it, rather than conflating the two.
Common mistake
Leaning on a botanical's traditional-use history as the entire justification for a modern supplement claim, without a standardised extract and supporting documentation behind it. Traditional use supports a story; it doesn't substitute for the compound-level consistency a regulator and a repeat customer both expect, batch after batch.
Turmeric
~20% share of medicinal plant types; standardised to curcuminoid content.
Ginseng
Fastest-growing plant type, over 10% CAGR.
Centella Asiatica
Native across Southeast Asia, widely used in beauty-from-within formulations.
Ginger
Established digestive-comfort category, standardised to gingerol content.
How Biox Nexevo Handles This
Standardised extracts, halal-verified from source.
Our botanical ingredient sourcing verifies compound standardisation and halal supply chain documentation together from the outset, so a traditional botanical's cultural story and its regulatory dossier are built in parallel, not reconciled after the fact — and every claim we help formulate stays anchored to what the standardised extract actually delivers.
It is a WHO policy framework that calls on member states to integrate evidence-based botanical therapies into national health systems, encouraging standardisation and clinical validation of traditional plant-based remedies rather than treating them as folk medicine outside formal healthcare structures.
One estimate values the herbal medicinal products market at approximately USD 263.84 billion in 2026, projected to reach USD 396.07 billion by 2031, growing at roughly 8.46% CAGR, with Asia-Pacific holding the largest regional revenue share.
Turmeric holds the largest single-ingredient share among medicinal plant types at close to 20%, while ginseng is the fastest-growing at over 10% CAGR. Centella asiatica, ginger, and Echinacea are also significant categories, particularly across Southeast and East Asian markets.
Traditional preparation methods vary widely and are difficult to reproduce reliably at commercial scale. Standardisation defines a consistent, measurable level of key active compounds in an extract, which is what allows a traditional remedy to become a regulated supplement ingredient with dependable labelling.
Capsules and softgels are the leading format, accounting for over half the category by revenue share, while powders remain popular for their versatility in food and beverage formulation. Gummies are the fastest-growing format, particularly among younger Asia-Pacific consumers.
Building a botanical supplement for ASEAN?
Talk to Us on WhatsAppSources: World Health Organization Traditional Medicine Global Strategy 2025-2034; Mordor Intelligence Herbal Medicinal Products Market report. Market figures are industry estimates and vary by source and methodology - confirm current figures directly with the research provider before citing in external materials.
Continue Exploring